Correlation of vascular endothelial growth factor and hypoxia-inducible factor-1α expression with pathological renal artery changes in patients with renal cell carcinoma

References

• Parkin CM, Whelan SL, Ferlay J, Teppo L, Thomas D. Cancer incidence in five continents. Volume VIII. IARC scientific publications no. 155 Lyon: International Agency for Research on Cancer; 2002.
   Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71–96.
   PubMed Web of Science ®Google Scholar
• Sun M, Lughezzani G, Perrotte P, Karakiewicz Pl. Treatment of metastatic renal cell carcinoma. Nat Rev Urol 2009;7:327–38.
   Google Scholar
• Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002;168:2395–400.
   PubMed Web of Science ®Google Scholar
• Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 2005;104:511–20.
   PubMed Web of Science ®Google Scholar
• Rosai J. Rosai and Ackerman's surgical pathology. 9th ed. St Louis, MO: Elsevier Mosby; 2004. p 1234–6.
   Google Scholar
• Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis 2007;2:28.
   PubMed Web of Science ®Google Scholar
• Sang CN, Whelton PK, Hamper UM, Connolly M, Kadir S, White RI, et al. Etiologic factors in renovascular fibromuscular dysplasia. A case–control study. Hypertension 1989;14:472–9.
   PubMed Web of Science ®Google Scholar
• Salceda S, Caro J. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997;272:22642–7.
   PubMed Web of Science ®Google Scholar
• Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr, Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel–Lindau protein. Proc Natl Acad Sci USA 1996;93:10595–9.
   PubMed Web of Science ®Google Scholar
• Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, et al. Hypoxia-inducible factor 1α in clear cell renal cell carcinoma. Clin Cancer Res 2007;13:7388–93.
   PubMed Web of Science ®Google Scholar
• Bullock A, McDermott DF, Atkins MB. Management of metastatic renal cell carcinoma in patients with poor prognosis. Cancer Manag Res 2010;2:123–32.
   Google Scholar
• Hemmerlein B, Kugler A, Ozisik R, Ringert RH, Radzun HJ, Thelen P. Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas. Virchows Arch 2001;439:645–52.
   PubMed Web of Science ®Google Scholar
• Paradis V, Lagha NB, Zeimoura L, Blanchet P, Eschwege P, Ba N, et al. Expression of vascular endothelial growth factor in renal cell carcinomas. Virchows Arch 2000;436:351–6.
   PubMed Web of Science ®Google Scholar
• Tomić K, Tomas D, Tomašković I, Kos M, Belicza M, Krušlin B. Renal artery changes in patients with primary renal cell carcinoma. Virchows Arch 2006;448:24–8.
   Google Scholar
• Krušlin B, Tomić K, Tomas D, Mladinov D, Trnski D, Belicza M. The correlation between the tumor necrosis and renal artery changes in renal cell carcinoma. Int J Surg Pathol 2006;14:312–19.
   Google Scholar
• Tomić K, Mladinov D, Batelja-Vuletić L, Spajic B, Mijic A, Tomas D, et al. Morphometric analysis of renal arteries in patients with renal cell carcinoma. Pathol Res Pract 2007;203:647–52.
   Google Scholar
• Yao X, Qian CN, Zhang ZF, Tan MH, Kort EJ, Yang XJ, et al. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res 2007;13:161–9.
   PubMedGoogle Scholar
• Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, et al. Soft-tissue sarcomas of adults, study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37–42.
   PubMed Web of Science ®Google Scholar
• Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655–63.
   PubMed Web of Science ®Google Scholar
• Kumar V, Abbas AK, Fausto N. Acute and chronic inflammation. In Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia, PA: Elsevier Saunders; 2005. p 47–86.
   Google Scholar
• Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 2000;60:1388–93.
   PubMed Web of Science ®Google Scholar
• Qian CN, Huang D, Wondergem B, Teh B. Complexity of tumor vasculature in clear cell renal cell carcinoma. Cancer 2009;115:2282–9.
   PubMed Web of Science ®Google Scholar
• Wiesener MS, Munchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, et al. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res 2001;61:5215–22.
   PubMed Web of Science ®Google Scholar
• Yilmazer D, Han U, Onal B. A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma. Int Urol Nephrol 2007;39:691–8.
   PubMedGoogle Scholar
• Hemmerlein B, Galuschka L, Pultzer N, Zischkau S, Heuser M. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas. Histopathology 2004;45:603–11.
   PubMedGoogle Scholar
• Raica M, Cimpean AM, Anghel A. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma. Neoplasma 2007;54:278–84.
   Google Scholar
• Yamakawa M, Liu LX, Belanger AJ, Date T, Kuriyama T, Goldberg MA, et al. Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis. Am J Physiol Renal Physiol 2004;87:F649–57.
   Google Scholar
• Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Vasko J, Ljungberg B. The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma. Clin Cancer Res 2005;11:1129–35.
   PubMed Web of Science ®Google Scholar
• Dorevic G, Matusan-Ilijas K, Babarovic E, Hadzisejdić I, Grahovac M, Grahovac B, et al. Hypoxia inducible factor-1alpha correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma. J Exp Clin Cancer Res 2009;28:40.
   PubMed Web of Science ®Google Scholar